[Use of brimonidine 0.2% in treatment of glaucoma or ocular hypertony after poorly tolerated beta-blocker treatment].

Titouamane, S; Baudouin, C

[Use of brimonidine 0.2% in treatment of glaucoma or ocular hypertony after poorly tolerated beta-blocker treatment]. / Intérêt de la brimonidine 0,2% dans le traitement du glaucome ou de l'hypertension intraoculaire après intolérance à un traitement par beta-bloquant.

Titouamane, S; Baudouin, C.

Affiliation

Titouamane S; CHNO des XV-XX, 28, rue de Charenton, 75012 Paris, France.

J Fr Ophtalmol ; 25(6): 568-75, 2002 Jun.

Article in Fr | MEDLINE | ID: mdl-12223942

Subject(s)

Adrenergic alpha-Agonists/therapeutic use; Adrenergic beta-Antagonists/therapeutic use; Glaucoma/drug therapy; Ocular Hypertension/drug therapy; Quinoxalines/therapeutic use; Adult; Appetite; Brimonidine Tartrate; Glaucoma/physiopathology; Glaucoma/psychology; Humans; Intraocular Pressure; Ocular Hypertension/physiopathology; Ocular Hypertension/psychology; Patient Satisfaction; Quality of Life; Surveys and Questionnaires; Treatment Failure; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinoxalines / Glaucoma / Ocular Hypertension / Adrenergic alpha-Agonists / Adrenergic beta-Antagonists Type of study: Clinical_trials / Observational_studies Aspects: Patient_preference Limits: Adult / Humans Language: Fr Journal: J Fr Ophtalmol Year: 2002 Document type: Article Affiliation country: France Country of publication: France

Search on Google

Add to My VHL

XML

PubMed Links